液气转换型阳离子超声纳米囊泡高效负载HOP-siRNA抑制肝癌射频消融术后复发进展的实验研究

基本信息
批准号:81801703
项目类别:青年科学基金项目
资助金额:21.00
负责人:陈淑玲
学科分类:
依托单位:中山大学
批准年份:2018
结题年份:2021
起止时间:2019-01-01 - 2021-12-31
项目状态: 已结题
项目参与者:高迪,徐明,陈立达,孙开宇,李薇,苏天洪,廖俊彬,戴子浩
关键词:
射频消融超声引导肝细胞癌应激诱导磷酸化蛋白1纳米囊泡
结项摘要

Ultrasound-guided radiofrequency ablation (RFA) is an important treatment modality for hepatocellular carcinoma (HCC). But it remains the serious problems of incomplete ablation and high recurrence after RFA, and there is no effective inhibitory method for these problems until now. Our preliminary results showed that heat stimulus could induce the increased expression of stress induced phosphoprotein-1(HOP) of HCC cells, and then promoted the proliferation and inhibited the apoptosis of HCC cells and induced the epithelial mesenchymal transition (EMT). These evidences suggest that HOP plays an important role in the tumor recurrence and progression after incomplete ablation. Nanodroplet is an effective gene delivery vector. Our research group has preliminarily established the ultrasound-triggered phase-transition cationic nanodroplet with high efficiency of gene delivery. In this research, we are going to bear HOP-siRNA within the droplet and to modify droplet surface with folic acid. Based on these, we hypothesized that under ultrasound mediation,nanodroplet bearing HOP-siRNA could efficiently deliver HOP-siRNA to residual HCC cells after incomplete RFA, which in turn inhibited tumor proliferation, EMT and promoted apoptosis. Our research is going to synthesize a HCC-targeted phase-transition cationic nanodroplet with HOP-siRNA delivery function, and to investigate its anti-tumor effect. Also, we combined it with RFA to explore its effect and mechanism on controlling tumor recurrence after RFA from cells and animal models, with the methods of PCR, western blotting, immunofluorescence and others. This study will provide a novel thicking in the inhibition of HCC recurrence after RFA.

超声引导下射频消融(RFA)是治疗肝癌的重要手段,但存在术后高残留高复发问题,目前尚无有效抑制手段。我们前期发现热刺激可致肝癌细胞应激诱导磷酸化蛋白1(HOP)表达增加,进而促进肝癌细胞增殖、抑制凋亡并介导EMT,提示HOP在肿瘤不全消融术后复发进展发挥作用。纳米囊泡是有效基因治疗载体,我们前期已制备出高效负载基因的液气转换型阳离子纳米囊泡,本研究将结合HOP-siRNA并对囊泡表面行叶酸修饰,形成肝癌靶向传输HOP-siRNA的一体化纳米囊泡。我们假设载HOP-siRNA纳米囊泡在超声介导下可高效传输靶基因到RFA术后残余肝癌细胞内,抑制肿瘤细胞增殖及EMT并诱导其凋亡。本研究拟构建上述纳米囊泡,检测其抑癌作用,并将其与RFA联用,从细胞及动物模型阐明载HOP-siRNA靶向纳米囊泡可有效控制肝癌RFA术后复发进展的作用及机制,为抑制肝癌RFA术后复发提供新思路。

项目摘要

超声引导下射频消融(RFA)是治疗肝癌的重要手段,但术后高残留高复发问题限制其进一步提高临床疗效,寻求有效抑制复发转移手段是本领域的重点难点问题。本研究按照计划顺利完成,针对“载HOP-siRNA纳米囊泡在超声介导下可高效传输靶基因到RFA术后残余肝癌细胞内抑制肿瘤细胞生长”的问题,项目构建了肝癌靶向传输HOP-siRNA的一体化超声纳米囊泡,对纳米囊泡进行了基本的特性表征、转染效能评估及细胞毒性评估等,在细胞实验及裸鼠原位肝癌模型上发现其具有抑制肝癌细胞生长迁移的能力,并进一步在裸鼠原位肝癌不全消融模型上将纳米囊泡与RFA联用,发现纳米囊泡联合RFA可有效抑制消融后残余肝癌细胞生长,从细胞及动物模型阐明载HOP-siRNA靶向纳米囊泡可有效控制肝癌RFA术后复发进展的作用,为抑制肝癌RFA术后复发提供新思路。

项目成果
{{index+1}}

{{i.achievement_title}}

{{i.achievement_title}}

DOI:{{i.doi}}
发表时间:{{i.publish_year}}

暂无此项成果

数据更新时间:2023-05-31

其他相关文献

1

基于一维TiO2纳米管阵列薄膜的β伏特效应研究

基于一维TiO2纳米管阵列薄膜的β伏特效应研究

DOI:10.7498/aps.67.20171903
发表时间:2018
2

Intensive photocatalytic activity enhancement of Bi5O7I via coupling with band structure and content adjustable BiOBrxI1-x

Intensive photocatalytic activity enhancement of Bi5O7I via coupling with band structure and content adjustable BiOBrxI1-x

DOI:10.1016/j.scib.2017.12.016
发表时间:2018
3

Asymmetric Synthesis of (S)-14-Methyl-1-octadecene, the Sex Pheromone of the Peach Leafminer Moth

Asymmetric Synthesis of (S)-14-Methyl-1-octadecene, the Sex Pheromone of the Peach Leafminer Moth

DOI:
发表时间:
4

七羟基异黄酮通过 Id1 影响结直肠癌细胞增殖

七羟基异黄酮通过 Id1 影响结直肠癌细胞增殖

DOI:
发表时间:
5

Sparse Coding Algorithm with Negentropy and Weighted ℓ1-Norm for Signal Reconstruction

Sparse Coding Algorithm with Negentropy and Weighted ℓ1-Norm for Signal Reconstruction

DOI:10.3390/e19110599
发表时间:2017

陈淑玲的其他基金

批准号:51409130
批准年份:2014
资助金额:25.00
项目类别:青年科学基金项目

相似国自然基金

1

负载siRNA的MR可视化纳米胶束靶向沉默VEGF/Snail基因抑制肝癌射频消融术后复发转移

批准号:81571774
批准年份:2015
负责人:朱康顺
学科分类:H2710
资助金额:65.00
项目类别:面上项目
2

Sorafenib阻断HIF-1/VEGF通路抑制超声引导下肝癌射频消融后快速进展及转移的实验研究

批准号:81371555
批准年份:2013
负责人:谢晓燕
学科分类:H2703
资助金额:70.00
项目类别:面上项目
3

肝癌射频消融后残留癌快速进展及其机制的实验研究

批准号:30872490
批准年份:2008
负责人:孙文兵
学科分类:H1817
资助金额:19.00
项目类别:面上项目
4

阿霉素温敏型免疫纳米微囊联合射频消融靶向治疗肝癌实验研究

批准号:30872996
批准年份:2008
负责人:罗葆明
学科分类:H1820
资助金额:30.00
项目类别:面上项目